Heinz Höfler focuses on Pathology, Cancer, Internal medicine, Cancer research and Carcinoma. The concepts of his Pathology study are interwoven with issues in Proteomics and Metastasis. His Cancer study incorporates themes from Missense mutation, Germline mutation and Survival analysis.
His Internal medicine research includes themes of Gastroenterology, Endocrinology and Oncology. His studies in Cancer research integrate themes in fields like Cisplatin, DNA methylation, Carcinogenesis, Mass spectrometry and Breast cancer. His Carcinoma study combines topics from a wide range of disciplines, such as Cadherin, Survival rate, Stomach, Exon and Chromosome instability.
His scientific interests lie mostly in Pathology, Cancer research, Internal medicine, Cancer and Immunohistochemistry. His research in Pathology is mostly concerned with Carcinoma. His study on Cancer research also encompasses disciplines like
His Internal medicine research includes elements of Gastroenterology and Oncology. Cancer is closely attributed to Survival analysis in his study. His study in the field of Tissue microarray also crosses realms of MALDI imaging.
The scientist’s investigation covers issues in Cancer research, Pathology, Internal medicine, Cancer and Immunohistochemistry. The study incorporates disciplines such as Protein kinase B, Cancer cell, Urokinase receptor, Breast cancer and PTEN in addition to Cancer research. Heinz Höfler interconnects PI3K/AKT/mTOR pathway, Colorectal cancer and Primary tumor, Metastasis in the investigation of issues within Pathology.
His studies deal with areas such as Immunology, Endocrinology and Oncology as well as Internal medicine. His Cancer research is multidisciplinary, incorporating perspectives in Retrospective cohort study, Survival analysis and Notch signaling pathway. As part of one scientific family, Heinz Höfler deals mainly with the area of Immunohistochemistry, narrowing it down to issues related to the Molecular biology, and often Antibody.
His primary scientific interests are in Pathology, Cancer, Internal medicine, MALDI imaging and Cancer research. His biological study spans a wide range of topics, including Colorectal cancer, KRAS, Chemotherapy and Intraepithelial neoplasia. Heinz Höfler has included themes like Survival analysis and Retrospective cohort study in his Cancer study.
Heinz Höfler combines subjects such as Endocrinology, Molecular pathology, Gene expression, Oncology and Mutation with his study of Internal medicine. His research in Cancer research intersects with topics in Gene knockdown and Cisplatin. His work carried out in the field of Proteomics brings together such families of science as Immunohistochemistry, Metastasis, Bioinformatics and Adenocarcinoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.
Karen Becker;James D. Mueller;Christoph Schulmacher;Katja Ott.
Cancer (2003)
Mutations of the human E‐cadherin (CDH1) gene
Geert Berx;Karl-Friedrich Becker;Heinz Höfler;Frans van Roy.
Human Mutation (1998)
Revised classification of neuroendocrine tumours of the lung, pancreas and gut.
C. Capella;P. U. Heitz;H. Höfler;E. Solcia.
Virchows Archiv (1995)
Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.
Natalia S. Pellegata;Leticia Quintanilla-Martinez;Heide Siggelkow;Elenore Samson.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Clinical impact of the plasminogen activation system in tumor invasion and metastasis : Prognostic relevance and target for therapy
M Schmitt;N Harbeck;C Thomssen;O Wilhelm.
Thrombosis and Haemostasis (1997)
HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
Josef Rüschoff;Manfred Dietel;Gustavo B Baretton;Susanne Arbogast.
Virchows Archiv (2010)
Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer
Fritz Jänicke;Manfred Schmitt;Lothar Pache;Kurt Ulm.
Breast Cancer Research and Treatment (1993)
Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.
Johannes Bange;Dieter Prechtl;Yuri Cheburkin;Katja Specht.
Cancer Research (2002)
Rapamycin extends murine lifespan but has limited effects on aging
Frauke Neff;Diana Flores-Dominguez;Devon P. Ryan;Marion Horsch.
Journal of Clinical Investigation (2013)
Quantification of CK20 gene and protein expression in colorectal cancer by RT-PCR and immunohistochemistry reveals inter- and intratumour heterogeneity.
Silke Lassmann;Markus Bauer;Richie Soong;Joachim Schreglmann.
The Journal of Pathology (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Technical University of Munich
University of Freiburg
Technical University of Munich
Paracelsus Medical University
Leipzig University
Ludwig-Maximilians-Universität München
McGill University
German Cancer Research Center
Charité - University Medicine Berlin
Technical University of Munich
Georgia Institute of Technology
ShanghaiTech University
Universitat Politècnica de València
University of Utah
University of Oxford
Central Leather Research Institute
Technical University of Denmark
Indiana University
University of Tsukuba
German Center for Neurodegenerative Diseases
University of Maryland, Baltimore
University of Colorado Boulder
University of Lille
Harvard University
Concordia University
University of Michigan–Ann Arbor